Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-324 | wolf-screen-ratio-mammosphere-adherent | 0.819 | 1.30e-06 | 3.47e-03 | 6.48e-03 | 6 | 4 |
int-snw-1457 | wolf-screen-ratio-mammosphere-adherent | 0.950 | 4.10e-16 | 1.76e-03 | 3.13e-02 | 6 | 5 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
EIF2S2 | 8894 | 39 | 1.075 | 0.940 | 103 | Yes | - |
PAFAH1B1 | 5048 | 17 | 0.691 | 0.819 | 126 | Yes | - |
HNRNPC | 3183 | 108 | 1.812 | 0.973 | 181 | Yes | - |
TP53 | 7157 | 23 | 0.432 | 0.833 | 665 | - | - |
RPL6 | 6128 | 37 | 0.844 | 1.113 | 164 | Yes | - |
RPL14 | 9045 | 49 | 1.250 | 1.113 | 166 | Yes | - |
CSNK2A1 | 1457 | 2 | 0.030 | 0.950 | 311 | - | - |
APC | 324 | 2 | 0.261 | 0.819 | 31 | - | - |
NCOA2 | 10499 | 2 | 0.469 | 0.819 | 95 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
APC | 324 | RPL14 | 9045 | pd | > | reg.ITFP.txt: no annot |
TP53 | 7157 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, BioGrid, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
APC | 324 | NCOA2 | 10499 | pd | <> | reg.ITFP.txt: no annot |
CSNK2A1 | 1457 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0217(phosphorylation reaction); int.I2D: BIND, BCI, HPRD; int.HPRD: in vitro |
PAFAH1B1 | 5048 | RPL14 | 9045 | pd | > | reg.ITFP.txt: no annot |
CSNK2A1 | 1457 | PAFAH1B1 | 5048 | pp | -- | int.I2D: HPRD, BCI, BioGrid; int.HPRD: in vitro |
CSNK2A1 | 1457 | TP53 | 7157 | pp | -- | int.Intact: MI:0217(phosphorylation reaction); int.I2D: BCI, HPRD; int.HPRD: in vitro, in vivo |
HNRNPC | 3183 | TP53 | 7157 | pd | < | reg.ITFP.txt: no annot |
APC | 324 | TP53 | 7157 | pd | < | reg.TRANSFAC.txt: no annot |
CSNK2A1 | 1457 | HNRNPC | 3183 | pp | -- | int.I2D: BCI; int.HPRD: in vitro, in vivo |
APC | 324 | PAFAH1B1 | 5048 | pd | <> | reg.ITFP.txt: no annot |
CSNK2A1 | 1457 | RPL6 | 6128 | pp | -- | int.Intact: MI:0217(phosphorylation reaction) |
PAFAH1B1 | 5048 | NCOA2 | 10499 | pd | <> | reg.ITFP.txt: no annot |
TP53 | 7157 | NCOA2 | 10499 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
APC | 324 | CSNK2A1 | 1457 | pp | -- | int.I2D: BioGrid |
RPL6 | 6128 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005829 | cytosol | 2.83e-06 | 4.62e-02 | 2.501 | 8 | 125 | 2562 |
GO:0003723 | RNA binding | 2.54e-05 | 4.15e-01 | 4.353 | 4 | 19 | 355 |
GO:0006413 | translational initiation | 4.10e-05 | 6.69e-01 | 5.376 | 3 | 12 | 131 |
GO:0033077 | T cell differentiation in thymus | 1.41e-04 | 1.00e+00 | 6.780 | 2 | 2 | 33 |
GO:0006412 | translation | 2.32e-04 | 1.00e+00 | 4.533 | 3 | 15 | 235 |
GO:0010467 | gene expression | 2.99e-04 | 1.00e+00 | 3.439 | 4 | 58 | 669 |
GO:0022625 | cytosolic large ribosomal subunit | 3.14e-04 | 1.00e+00 | 6.210 | 2 | 5 | 49 |
GO:0045732 | positive regulation of protein catabolic process | 3.40e-04 | 1.00e+00 | 6.152 | 2 | 4 | 51 |
GO:0000776 | kinetochore | 5.19e-04 | 1.00e+00 | 5.847 | 2 | 4 | 63 |
GO:0000235 | astral microtubule | 5.51e-04 | 1.00e+00 | 10.825 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 5.51e-04 | 1.00e+00 | 10.825 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 5.51e-04 | 1.00e+00 | 10.825 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 5.51e-04 | 1.00e+00 | 10.825 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 5.51e-04 | 1.00e+00 | 10.825 | 1 | 1 | 1 |
GO:0019083 | viral transcription | 8.56e-04 | 1.00e+00 | 5.485 | 2 | 8 | 81 |
GO:0047485 | protein N-terminus binding | 9.65e-04 | 1.00e+00 | 5.398 | 2 | 4 | 86 |
GO:0006415 | translational termination | 9.87e-04 | 1.00e+00 | 5.382 | 2 | 8 | 87 |
GO:0097252 | oligodendrocyte apoptotic process | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 2 |
GO:0051081 | nuclear envelope disassembly | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 2 | 2 |
GO:1901525 | negative regulation of macromitophagy | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 2 |
GO:0036035 | osteoclast development | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 2 | 2 |
GO:0090343 | positive regulation of cell aging | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 2 |
GO:0009798 | axis specification | 1.10e-03 | 1.00e+00 | 9.825 | 1 | 1 | 2 |
GO:0006414 | translational elongation | 1.13e-03 | 1.00e+00 | 5.285 | 2 | 11 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.41e-03 | 1.00e+00 | 5.124 | 2 | 8 | 104 |
GO:0006461 | protein complex assembly | 1.60e-03 | 1.00e+00 | 5.030 | 2 | 6 | 111 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0051097 | negative regulation of helicase activity | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0002360 | T cell lineage commitment | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0034103 | regulation of tissue remodeling | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0045505 | dynein intermediate chain binding | 1.65e-03 | 1.00e+00 | 9.240 | 1 | 1 | 3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.69e-03 | 1.00e+00 | 4.992 | 2 | 10 | 114 |
GO:0019058 | viral life cycle | 1.72e-03 | 1.00e+00 | 4.979 | 2 | 10 | 115 |
GO:0044822 | poly(A) RNA binding | 1.82e-03 | 1.00e+00 | 2.750 | 4 | 50 | 1078 |
GO:0006355 | regulation of transcription, DNA-templated | 1.99e-03 | 1.00e+00 | 2.716 | 4 | 17 | 1104 |
GO:0044267 | cellular protein metabolic process | 2.03e-03 | 1.00e+00 | 3.458 | 3 | 24 | 495 |
GO:0007050 | cell cycle arrest | 2.05e-03 | 1.00e+00 | 4.847 | 2 | 7 | 126 |
GO:0071174 | mitotic spindle checkpoint | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 4 |
GO:0090403 | oxidative stress-induced premature senescence | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 4 |
GO:0030375 | thyroid hormone receptor coactivator activity | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 4 |
GO:0002326 | B cell lineage commitment | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 2.20e-03 | 1.00e+00 | 8.825 | 1 | 2 | 4 |
GO:0000790 | nuclear chromatin | 2.29e-03 | 1.00e+00 | 4.769 | 2 | 7 | 133 |
GO:0005515 | protein binding | 2.36e-03 | 1.00e+00 | 1.244 | 8 | 172 | 6127 |
GO:0003735 | structural constituent of ribosome | 2.56e-03 | 1.00e+00 | 4.685 | 2 | 8 | 141 |
GO:0016032 | viral process | 2.61e-03 | 1.00e+00 | 3.333 | 3 | 55 | 540 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 2.75e-03 | 1.00e+00 | 8.503 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 2.75e-03 | 1.00e+00 | 8.503 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 2.75e-03 | 1.00e+00 | 8.503 | 1 | 1 | 5 |
GO:0008017 | microtubule binding | 2.90e-03 | 1.00e+00 | 4.596 | 2 | 7 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 3.21e-03 | 1.00e+00 | 4.521 | 2 | 8 | 158 |
GO:0030858 | positive regulation of epithelial cell differentiation | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0001667 | ameboidal-type cell migration | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0008090 | retrograde axon cargo transport | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0034452 | dynactin binding | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0070245 | positive regulation of thymocyte apoptotic process | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 3.30e-03 | 1.00e+00 | 8.240 | 1 | 1 | 6 |
GO:0007097 | nuclear migration | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0017145 | stem cell division | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0031497 | chromatin assembly | 3.85e-03 | 1.00e+00 | 8.017 | 1 | 1 | 7 |
GO:0045670 | regulation of osteoclast differentiation | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 8 |
GO:0000733 | DNA strand renaturation | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 8 |
GO:0031512 | motile primary cilium | 4.40e-03 | 1.00e+00 | 7.825 | 1 | 1 | 8 |
GO:0006983 | ER overload response | 4.95e-03 | 1.00e+00 | 7.655 | 1 | 2 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 4.95e-03 | 1.00e+00 | 7.655 | 1 | 1 | 9 |
GO:0032319 | regulation of Rho GTPase activity | 4.95e-03 | 1.00e+00 | 7.655 | 1 | 2 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 4.95e-03 | 1.00e+00 | 7.655 | 1 | 1 | 9 |
GO:0045667 | regulation of osteoblast differentiation | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 10 |
GO:0090399 | replicative senescence | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 10 |
GO:0001675 | acrosome assembly | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 10 |
GO:0030877 | beta-catenin destruction complex | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 2 | 10 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.50e-03 | 1.00e+00 | 7.503 | 1 | 1 | 10 |
GO:0001701 | in utero embryonic development | 5.59e-03 | 1.00e+00 | 4.110 | 2 | 6 | 210 |
GO:0045502 | dynein binding | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 2 | 11 |
GO:0051010 | microtubule plus-end binding | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 11 |
GO:0008340 | determination of adult lifespan | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 11 |
GO:0071850 | mitotic cell cycle arrest | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 3 | 11 |
GO:0045120 | pronucleus | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 11 |
GO:2000273 | positive regulation of receptor activity | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 2 | 11 |
GO:0021819 | layer formation in cerebral cortex | 6.05e-03 | 1.00e+00 | 7.365 | 1 | 1 | 11 |
GO:0016071 | mRNA metabolic process | 6.28e-03 | 1.00e+00 | 4.024 | 2 | 34 | 223 |
GO:0032886 | regulation of microtubule-based process | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 4 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 2 | 12 |
GO:0016580 | Sin3 complex | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 12 |
GO:0047496 | vesicle transport along microtubule | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 12 |
GO:0045295 | gamma-catenin binding | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 12 |
GO:0070266 | necroptotic process | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 12 |
GO:0032461 | positive regulation of protein oligomerization | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 12 |
GO:0009303 | rRNA transcription | 6.60e-03 | 1.00e+00 | 7.240 | 1 | 1 | 12 |
GO:0042273 | ribosomal large subunit biogenesis | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 4 | 13 |
GO:0044295 | axonal growth cone | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 13 |
GO:0008266 | poly(U) RNA binding | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 13 |
GO:0008134 | transcription factor binding | 7.60e-03 | 1.00e+00 | 3.882 | 2 | 8 | 246 |
GO:0016070 | RNA metabolic process | 7.66e-03 | 1.00e+00 | 3.876 | 2 | 34 | 247 |
GO:0035371 | microtubule plus-end | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 2 | 14 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 14 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 14 |
GO:0009651 | response to salt stress | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 2 | 14 |
GO:0048568 | embryonic organ development | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 14 |
GO:0048854 | brain morphogenesis | 8.24e-03 | 1.00e+00 | 6.918 | 1 | 1 | 15 |
GO:0016581 | NuRD complex | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 16 |
GO:0007405 | neuroblast proliferation | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 16 |
GO:0007026 | negative regulation of microtubule depolymerization | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 2 | 16 |
GO:0019226 | transmission of nerve impulse | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 4 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 8.79e-03 | 1.00e+00 | 6.825 | 1 | 1 | 16 |
GO:0010906 | regulation of glucose metabolic process | 9.34e-03 | 1.00e+00 | 6.737 | 1 | 1 | 17 |
GO:0042149 | cellular response to glucose starvation | 9.34e-03 | 1.00e+00 | 6.737 | 1 | 1 | 17 |
GO:0043274 | phospholipase binding | 9.34e-03 | 1.00e+00 | 6.737 | 1 | 1 | 17 |
GO:0051879 | Hsp90 protein binding | 9.34e-03 | 1.00e+00 | 6.737 | 1 | 1 | 17 |
GO:0043065 | positive regulation of apoptotic process | 9.35e-03 | 1.00e+00 | 3.726 | 2 | 8 | 274 |
GO:0016922 | ligand-dependent nuclear receptor binding | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 1 | 18 |
GO:0031122 | cytoplasmic microtubule organization | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 2 | 18 |
GO:0051721 | protein phosphatase 2A binding | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 1 | 18 |
GO:0045773 | positive regulation of axon extension | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 2 | 18 |
GO:0005657 | replication fork | 9.88e-03 | 1.00e+00 | 6.655 | 1 | 3 | 18 |
GO:0035035 | histone acetyltransferase binding | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 19 |
GO:0071158 | positive regulation of cell cycle arrest | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 2 | 19 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 19 |
GO:0035257 | nuclear hormone receptor binding | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 19 |
GO:0002931 | response to ischemia | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 20 |
GO:0043234 | protein complex | 1.11e-02 | 1.00e+00 | 3.596 | 2 | 17 | 300 |
GO:0009306 | protein secretion | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 21 |
GO:0008156 | negative regulation of DNA replication | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 21 |
GO:0007369 | gastrulation | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 2 | 21 |
GO:0005669 | transcription factor TFIID complex | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 22 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 4 | 22 |
GO:0019901 | protein kinase binding | 1.26e-02 | 1.00e+00 | 3.503 | 2 | 21 | 320 |
GO:0016573 | histone acetylation | 1.26e-02 | 1.00e+00 | 6.301 | 1 | 2 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.26e-02 | 1.00e+00 | 6.301 | 1 | 4 | 23 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 4 | 24 |
GO:0001836 | release of cytochrome c from mitochondria | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 2 | 24 |
GO:0046329 | negative regulation of JNK cascade | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 24 |
GO:0000060 | protein import into nucleus, translocation | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 4 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.32e-02 | 1.00e+00 | 6.240 | 1 | 1 | 24 |
GO:0031519 | PcG protein complex | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 4 | 25 |
GO:0007569 | cell aging | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 2 | 25 |
GO:0003682 | chromatin binding | 1.37e-02 | 1.00e+00 | 3.441 | 2 | 12 | 334 |
GO:0045296 | cadherin binding | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 2 | 25 |
GO:0071479 | cellular response to ionizing radiation | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 1 | 25 |
GO:0005813 | centrosome | 1.41e-02 | 1.00e+00 | 3.419 | 2 | 12 | 339 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 1 | 26 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.42e-02 | 1.00e+00 | 6.124 | 1 | 3 | 26 |
GO:0030177 | positive regulation of Wnt signaling pathway | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 3 | 28 |
GO:0005875 | microtubule associated complex | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 2 | 28 |
GO:0007017 | microtubule-based process | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 3 | 28 |
GO:0031492 | nucleosomal DNA binding | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 4 | 28 |
GO:0031252 | cell leading edge | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 3 | 29 |
GO:0005913 | cell-cell adherens junction | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 2 | 29 |
GO:0010332 | response to gamma radiation | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 2 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 1.59e-02 | 1.00e+00 | 5.967 | 1 | 2 | 29 |
GO:0010977 | negative regulation of neuron projection development | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 2 | 30 |
GO:0051262 | protein tetramerization | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 3 | 30 |
GO:0008285 | negative regulation of cell proliferation | 1.64e-02 | 1.00e+00 | 3.305 | 2 | 11 | 367 |
GO:0021549 | cerebellum development | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.64e-02 | 1.00e+00 | 5.918 | 1 | 2 | 30 |
GO:0046677 | response to antibiotic | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 2 | 31 |
GO:0016604 | nuclear body | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 2 | 31 |
GO:0061077 | chaperone-mediated protein folding | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 2 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.70e-02 | 1.00e+00 | 5.870 | 1 | 5 | 31 |
GO:0009953 | dorsal/ventral pattern formation | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 1 | 32 |
GO:0051219 | phosphoprotein binding | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 3 | 32 |
GO:0034644 | cellular response to UV | 1.75e-02 | 1.00e+00 | 5.825 | 1 | 5 | 32 |
GO:0030971 | receptor tyrosine kinase binding | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 2 | 33 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 33 |
GO:0070830 | tight junction assembly | 1.81e-02 | 1.00e+00 | 5.780 | 1 | 1 | 33 |
GO:0007611 | learning or memory | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 2 | 34 |
GO:0005654 | nucleoplasm | 1.86e-02 | 1.00e+00 | 2.313 | 3 | 83 | 1095 |
GO:0001085 | RNA polymerase II transcription factor binding | 1.86e-02 | 1.00e+00 | 5.737 | 1 | 2 | 34 |
GO:0000278 | mitotic cell cycle | 1.91e-02 | 1.00e+00 | 3.188 | 2 | 52 | 398 |
GO:0001942 | hair follicle development | 1.91e-02 | 1.00e+00 | 5.695 | 1 | 2 | 35 |
GO:0051402 | neuron apoptotic process | 1.97e-02 | 1.00e+00 | 5.655 | 1 | 2 | 36 |
GO:0048538 | thymus development | 1.97e-02 | 1.00e+00 | 5.655 | 1 | 2 | 36 |
GO:0001756 | somitogenesis | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 38 |
GO:0021766 | hippocampus development | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 4 | 39 |
GO:0051781 | positive regulation of cell division | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 39 |
GO:0006284 | base-excision repair | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 7 | 39 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.18e-02 | 1.00e+00 | 5.503 | 1 | 2 | 40 |
GO:0035019 | somatic stem cell maintenance | 2.18e-02 | 1.00e+00 | 5.503 | 1 | 2 | 40 |
GO:0005881 | cytoplasmic microtubule | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 2 | 41 |
GO:0045785 | positive regulation of cell adhesion | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 5 | 41 |
GO:0050885 | neuromuscular process controlling balance | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 41 |
GO:0021987 | cerebral cortex development | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 3 | 42 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 3 | 43 |
GO:0004402 | histone acetyltransferase activity | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 1 | 43 |
GO:0034613 | cellular protein localization | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 44 |
GO:0005871 | kinesin complex | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 44 |
GO:0016328 | lateral plasma membrane | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 2 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.51e-02 | 1.00e+00 | 5.301 | 1 | 2 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 5 | 47 |
GO:0008344 | adult locomotory behavior | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 1 | 47 |
GO:0048511 | rhythmic process | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 2 | 47 |
GO:0005507 | copper ion binding | 2.62e-02 | 1.00e+00 | 5.240 | 1 | 2 | 48 |
GO:0003743 | translation initiation factor activity | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 4 | 49 |
GO:0035690 | cellular response to drug | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 2 | 50 |
GO:0003684 | damaged DNA binding | 2.78e-02 | 1.00e+00 | 5.152 | 1 | 11 | 51 |
GO:0042802 | identical protein binding | 2.83e-02 | 1.00e+00 | 2.885 | 2 | 18 | 491 |
GO:0016042 | lipid catabolic process | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 52 |
GO:0060041 | retina development in camera-type eye | 2.89e-02 | 1.00e+00 | 5.097 | 1 | 3 | 53 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.94e-02 | 1.00e+00 | 5.070 | 1 | 5 | 54 |
GO:0000226 | microtubule cytoskeleton organization | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 3 | 55 |
GO:0097193 | intrinsic apoptotic signaling pathway | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 4 | 55 |
GO:0002039 | p53 binding | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 7 | 55 |
GO:0008104 | protein localization | 3.05e-02 | 1.00e+00 | 5.017 | 1 | 3 | 56 |
GO:0051087 | chaperone binding | 3.21e-02 | 1.00e+00 | 4.942 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 4 | 60 |
GO:0006302 | double-strand break repair | 3.37e-02 | 1.00e+00 | 4.870 | 1 | 8 | 62 |
GO:0019903 | protein phosphatase binding | 3.42e-02 | 1.00e+00 | 4.847 | 1 | 4 | 63 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.42e-02 | 1.00e+00 | 4.847 | 1 | 1 | 63 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.48e-02 | 1.00e+00 | 4.825 | 1 | 1 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 22 | 65 |
GO:0007409 | axonogenesis | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 66 |
GO:0006289 | nucleotide-excision repair | 3.74e-02 | 1.00e+00 | 4.716 | 1 | 12 | 69 |
GO:0006915 | apoptotic process | 3.74e-02 | 1.00e+00 | 2.667 | 2 | 34 | 571 |
GO:0030307 | positive regulation of cell growth | 3.80e-02 | 1.00e+00 | 4.695 | 1 | 2 | 70 |
GO:0035264 | multicellular organism growth | 3.80e-02 | 1.00e+00 | 4.695 | 1 | 1 | 70 |
GO:0032587 | ruffle membrane | 3.90e-02 | 1.00e+00 | 4.655 | 1 | 4 | 72 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.96e-02 | 1.00e+00 | 2.622 | 2 | 12 | 589 |
GO:0000785 | chromatin | 3.96e-02 | 1.00e+00 | 4.635 | 1 | 5 | 73 |
GO:0002020 | protease binding | 4.01e-02 | 1.00e+00 | 4.615 | 1 | 4 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 3 | 75 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 75 |
GO:0007265 | Ras protein signal transduction | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 3 | 75 |
GO:0008584 | male gonad development | 4.17e-02 | 1.00e+00 | 4.558 | 1 | 2 | 77 |
GO:0001822 | kidney development | 4.27e-02 | 1.00e+00 | 4.521 | 1 | 3 | 79 |
GO:0071013 | catalytic step 2 spliceosome | 4.27e-02 | 1.00e+00 | 4.521 | 1 | 7 | 79 |
GO:0005681 | spliceosomal complex | 4.49e-02 | 1.00e+00 | 4.449 | 1 | 3 | 83 |
GO:0009952 | anterior/posterior pattern specification | 4.54e-02 | 1.00e+00 | 4.432 | 1 | 2 | 84 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 3 | 88 |
GO:0016363 | nuclear matrix | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 11 | 92 |
GO:0005923 | tight junction | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 2 | 92 |
GO:0016605 | PML body | 4.96e-02 | 1.00e+00 | 4.301 | 1 | 5 | 92 |
GO:0001649 | osteoblast differentiation | 5.12e-02 | 1.00e+00 | 4.255 | 1 | 6 | 95 |
GO:0001764 | neuron migration | 5.17e-02 | 1.00e+00 | 4.240 | 1 | 2 | 96 |
GO:0006364 | rRNA processing | 5.17e-02 | 1.00e+00 | 4.240 | 1 | 5 | 96 |
GO:0030426 | growth cone | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 3 | 97 |
GO:0071456 | cellular response to hypoxia | 5.28e-02 | 1.00e+00 | 4.210 | 1 | 4 | 98 |
GO:0005938 | cell cortex | 5.85e-02 | 1.00e+00 | 4.056 | 1 | 3 | 109 |
GO:0030308 | negative regulation of cell growth | 6.06e-02 | 1.00e+00 | 4.004 | 1 | 6 | 113 |
GO:0005635 | nuclear envelope | 6.22e-02 | 1.00e+00 | 3.967 | 1 | 6 | 116 |
GO:0016020 | membrane | 6.27e-02 | 1.00e+00 | 1.640 | 3 | 80 | 1746 |
GO:0007219 | Notch signaling pathway | 6.69e-02 | 1.00e+00 | 3.859 | 1 | 4 | 125 |
GO:0008201 | heparin binding | 6.79e-02 | 1.00e+00 | 3.836 | 1 | 2 | 127 |
GO:0030036 | actin cytoskeleton organization | 6.89e-02 | 1.00e+00 | 3.813 | 1 | 5 | 129 |
GO:0030027 | lamellipodium | 6.95e-02 | 1.00e+00 | 3.802 | 1 | 4 | 130 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.95e-02 | 1.00e+00 | 3.802 | 1 | 3 | 130 |
GO:0030335 | positive regulation of cell migration | 6.95e-02 | 1.00e+00 | 3.802 | 1 | 6 | 130 |
GO:0046983 | protein dimerization activity | 7.00e-02 | 1.00e+00 | 3.791 | 1 | 3 | 131 |
GO:0016477 | cell migration | 7.00e-02 | 1.00e+00 | 3.791 | 1 | 6 | 131 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.04e-02 | 1.00e+00 | 2.161 | 2 | 19 | 811 |
GO:0000086 | G2/M transition of mitotic cell cycle | 7.31e-02 | 1.00e+00 | 3.726 | 1 | 7 | 137 |
GO:0044255 | cellular lipid metabolic process | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 4 | 140 |
GO:0016055 | Wnt signaling pathway | 7.51e-02 | 1.00e+00 | 3.685 | 1 | 6 | 141 |
GO:0042981 | regulation of apoptotic process | 8.03e-02 | 1.00e+00 | 3.586 | 1 | 26 | 151 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 8.03e-02 | 1.00e+00 | 3.586 | 1 | 2 | 151 |
GO:0000398 | mRNA splicing, via spliceosome | 8.74e-02 | 1.00e+00 | 3.458 | 1 | 12 | 165 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.89e-02 | 1.00e+00 | 3.432 | 1 | 5 | 168 |
GO:0044212 | transcription regulatory region DNA binding | 9.05e-02 | 1.00e+00 | 3.407 | 1 | 6 | 171 |
GO:0030424 | axon | 9.10e-02 | 1.00e+00 | 3.398 | 1 | 3 | 172 |
GO:0007165 | signal transduction | 9.28e-02 | 1.00e+00 | 1.933 | 2 | 17 | 950 |
GO:0031965 | nuclear membrane | 9.30e-02 | 1.00e+00 | 3.365 | 1 | 4 | 176 |
GO:0005634 | nucleus | 9.37e-02 | 1.00e+00 | 0.909 | 5 | 131 | 4828 |
GO:0031625 | ubiquitin protein ligase binding | 9.50e-02 | 1.00e+00 | 3.333 | 1 | 13 | 180 |
GO:0004871 | signal transducer activity | 1.13e-01 | 1.00e+00 | 3.070 | 1 | 4 | 216 |
GO:0007067 | mitotic nuclear division | 1.20e-01 | 1.00e+00 | 2.973 | 1 | 13 | 231 |
GO:0005759 | mitochondrial matrix | 1.21e-01 | 1.00e+00 | 2.960 | 1 | 12 | 233 |
GO:0008380 | RNA splicing | 1.21e-01 | 1.00e+00 | 2.967 | 1 | 13 | 232 |
GO:0003713 | transcription coactivator activity | 1.24e-01 | 1.00e+00 | 2.924 | 1 | 10 | 239 |
GO:0043025 | neuronal cell body | 1.32e-01 | 1.00e+00 | 2.836 | 1 | 4 | 254 |
GO:0000166 | nucleotide binding | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 6 | 272 |
GO:0019899 | enzyme binding | 1.48e-01 | 1.00e+00 | 2.655 | 1 | 11 | 288 |
GO:0070062 | extracellular vesicular exosome | 1.50e-01 | 1.00e+00 | 1.113 | 3 | 98 | 2516 |
GO:0005737 | cytoplasm | 1.54e-01 | 1.00e+00 | 0.867 | 4 | 98 | 3976 |
GO:0004674 | protein serine/threonine kinase activity | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 6 | 312 |
GO:0030154 | cell differentiation | 1.66e-01 | 1.00e+00 | 2.480 | 1 | 5 | 325 |
GO:0003677 | DNA binding | 1.67e-01 | 1.00e+00 | 1.425 | 2 | 26 | 1351 |
GO:0007411 | axon guidance | 1.67e-01 | 1.00e+00 | 2.471 | 1 | 9 | 327 |
GO:0008283 | cell proliferation | 1.68e-01 | 1.00e+00 | 2.454 | 1 | 12 | 331 |
GO:0005524 | ATP binding | 1.68e-01 | 1.00e+00 | 1.422 | 2 | 46 | 1354 |
GO:0007275 | multicellular organismal development | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 5 | 344 |
GO:0007268 | synaptic transmission | 1.79e-01 | 1.00e+00 | 2.361 | 1 | 2 | 353 |
GO:0005925 | focal adhesion | 1.87e-01 | 1.00e+00 | 2.293 | 1 | 18 | 370 |
GO:0007155 | cell adhesion | 1.93e-01 | 1.00e+00 | 2.240 | 1 | 8 | 384 |
GO:0008284 | positive regulation of cell proliferation | 1.97e-01 | 1.00e+00 | 2.210 | 1 | 8 | 392 |
GO:0046982 | protein heterodimerization activity | 2.00e-01 | 1.00e+00 | 2.184 | 1 | 11 | 399 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.11e-01 | 1.00e+00 | 2.097 | 1 | 14 | 424 |
GO:0006351 | transcription, DNA-templated | 2.15e-01 | 1.00e+00 | 1.194 | 2 | 25 | 1585 |
GO:0043066 | negative regulation of apoptotic process | 2.15e-01 | 1.00e+00 | 2.066 | 1 | 30 | 433 |
GO:0007596 | blood coagulation | 2.29e-01 | 1.00e+00 | 1.967 | 1 | 14 | 464 |
GO:0006468 | protein phosphorylation | 2.30e-01 | 1.00e+00 | 1.957 | 1 | 10 | 467 |
GO:0005730 | nucleolus | 2.36e-01 | 1.00e+00 | 1.107 | 2 | 70 | 1684 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.39e-01 | 1.00e+00 | 1.897 | 1 | 17 | 487 |
GO:0048471 | perinuclear region of cytoplasm | 2.54e-01 | 1.00e+00 | 1.794 | 1 | 12 | 523 |
GO:0005783 | endoplasmic reticulum | 2.90e-01 | 1.00e+00 | 1.572 | 1 | 9 | 610 |
GO:0042803 | protein homodimerization activity | 2.93e-01 | 1.00e+00 | 1.555 | 1 | 11 | 617 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.44e-01 | 1.00e+00 | 1.278 | 1 | 11 | 748 |
GO:0005739 | mitochondrion | 4.49e-01 | 1.00e+00 | 0.794 | 1 | 24 | 1046 |
GO:0008270 | zinc ion binding | 4.56e-01 | 1.00e+00 | 0.765 | 1 | 12 | 1067 |
GO:0005886 | plasma membrane | 4.81e-01 | 1.00e+00 | 0.356 | 2 | 38 | 2834 |
GO:0044281 | small molecule metabolic process | 5.25e-01 | 1.00e+00 | 0.486 | 1 | 57 | 1295 |
GO:0046872 | metal ion binding | 5.71e-01 | 1.00e+00 | 0.308 | 1 | 24 | 1465 |